Our results suggested that Lon-induced Ca2+-dependent cisplatin resistance is involved in chemotherapy-induced cancer stemness, which is consistent with the reported roles of PYK2, SRC, and STAT3/IL-6 in the enrichment of cancer stem cells [32, 52]. Here, IL6 is linked to cancer.